Ophthalmology Journal, 2016;9(2):30-35 Received: 24.02.2016 Accepted: 24.03.2016 G Objective. The aim of the study was to conduct clinical economic analysis of aflibercept (AFL) treatment compared to that of ranibizumab (RBZ) in patients with wet age-related macular degeneration (wAMD) in the Russian Federation Healthcare healthcare conditions. Materials and methods. Only direct medical costs were taken into account in this studyconsidered. These included costs of